联合CEUS LI-RADS与AFP评估肝脏病灶
回顾757例有HCC风险的孤立性肝结节患者,按CEUS LI-RADS v2017分类,将LR-3、LR-4、LR-M中AFP>200 ng/ml者重新分类为mLR-5。联合方案使敏感度从64.7%升至79.6%(P<0.001),特异度与PPV保持高位(96.6%和98.7%,P>0.050)。
要点
- LR-5预测HCC的敏感度64.7%、特异度97.8%、PPV 98.9%。
- AFP>200 ng/ml者占32.1%,其中98.8%为HCC。
- 联合AFP后敏感度升至79.6%(P<0.001),特异度96.6%、PPV 98.7%。
核心结论
- 联合CEUS LI-RADS与AFP诊断HCC可显著提高诊断敏感度,同时保持较高的PPV和特异度。
研究设计与样本
- 757例有HCC风险的757个孤立性肝结节,行CEUS和血清AFP检测,按CEUS LI-RADS 2017版分类为LR-1至LR-5及LR-M。
诊断标准与关键数值
- LR-5预测HCC的敏感度64.7%、特异度97.8%、PPV 98.9%。
临床应用与阅片要点
- 将LR-3、LR-4、LR-M中AFP>200 ng/ml者重新分类为mLR-5,与LR-5共同视为明确HCC。
- 修改后联合方案敏感度79.6%(P<0.001),特异度96.6%、PPV 98.7%(P>0.050)。
- AFP>200 ng/ml者中98.8%为HCC(LR-M占25.8%、LR-4占7.5%、LR-3占2.5%),1.2%为混合型肝细胞-胆管细胞癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To improve noninvasive diagnosis of HCC using a combination of CE US LI-RADS and alpha-fetoprotein (AFP).
METHODS: 757 solitary liver nodules from 757 patients at risk of HCC with CE US and serum AFP test were categorized as LR-1 to LR-5 through LR-M according to CE US LI-RADS version 2017. In LR-3, LR-4, and LR-M nodules, those with AFP > 200 ng/ml were reclassified as mLR-5. Nodules with LR-5 and mLR-5 were reclassified as definitely HCC to modify CE US LI-RADS. Diagnostic performance was assessed with specificity, sensitivity, and PPV.
RESULTS: The sensitivity, specificity, and PPV of LR-5 as a predictor of HCC were 64.7%, 97.8%, and 98.9%, respectively. 32.1% patients with solitary liver nodule had AFP greater than 200 ng/ml, of which 98.8% were HCC (25.8%, 7.5%, 2.5% assigned to LR-M, LR-4, LR-3, respectively) and 1.2% were Combined Hepatocellular Cholangiocarcinoma. After modification, the sensitivity increased to 79.6% (P < 0.001), while specificity and PPV remained high (96.6% and 98.7%, P > 0.050).
CONCLUSION: The combination of CE US LI-RADS and AFP for diagnosing HCC improved diagnostic sensitivity significantly, while maintaining high PPV and specificity in patients with the solitary liver nodule.
引用
- Li, Huang, Ruan, et al. An assessment of liver lesions using a combination of CEUS LI-RADS and AFP. Abdom Radiol (NY). 2022. PMID: 35122491. doi:10.1007/s00261-022-03428-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。